Evermine50 – Drug Eluting Stent (DES) – Meril Vascular Intervention
by Snehal Mehta Medical Professional
Snehal Mehta Medical Professional
EVERMINE50
Breakthrough in DES Technology:
Ultra-low strut thickness of 50μm for promoting early vascular healing
Variable strut width and variable crown design to ensure adequate radial strength of 1.1bar*
Hybrid cell stent design: Open cells in the middle of the stent for side-branch access and closed cell design on ends for optimal scaffolding and conformability
Clinically established drug everolimus with biodegradable polymer for proven clinical safety & long term efficacy
*Bench test data on file at Meril Life Sciences
Visit our website to learn more about the product.
https://www.merillife.com/medical-devices/vascular-intervention/coronary...
Jul 2nd 2019 01:58
EVERMINE50
Breakthrough in DES Technology:
Ultra-low strut thickness of 50μm for promoting early vascular healing
Variable strut width and variable crown design to ensure adequate radial strength of 1.1bar*
Hybrid cell stent design: Open cells in the middle of the stent for side-branch access and closed cell design on ends for optimal scaffolding and conformability
Clinically established drug everolimus with biodegradable polymer for proven clinical safety & long term efficacy
*Bench test data on file at Meril Life Sciences
Visit our website to learn more about the product.
https://www.merillife.com/medical-devices/vascular-intervention/coronary...
Jul 2nd 2019 01:58
Sponsor Ads
Comments
No comment, be the first to comment.